Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction - Results of a randomized trial

被引:32
作者
Barnett, PG
Chen, S
Boden, WE
Chow, B
Every, NR
Lavori, PW
Hlatky, MA
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA
[3] Syracuse VA Med Ctr, Syracuse, NY USA
[4] VA Puget Sound Hlth Care Syst, Seattle, WA USA
关键词
cost-benefit analysis; myocardial infarction; angiography; tests;
D O I
10.1161/hc0602.103584
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Use of coronary angiography after myocardial infarction has been controversial, with some physicians advocating routine use and others advocating selective use only after documentation of residual myocardial ischemia. The effects of these strategies on economic outcomes have not been established. Methods and Results-We analyzed data from a randomized, controlled clinical trial conducted in 17 Department of Veterans Affairs hospitals that enrolled 876 clinically uncomplicated patients 24 to 72 hours after an acute non-Q-wave myocardial infarction. The routine invasive strategy included early coronary angiography with revascularization based on established guidelines. The conservative, ischemia-guided strategy included noninvasive testing with radionuclide ventriculography and exercise thallium scintigraphy, followed by coronary angiography in patients with objective evidence of myocardial ischemia. We measured the cost of hospitalization and outpatient visits and tests during follow-up and calculated the incremental cost-effectiveness ratio. The conservative, ischemia-guided strategy had lower costs than the routine invasive strategy, both during the initial hospitalization ($14 733 versus $19 256, P<0.001) and after a mean follow-up of 1.9 years ($39 707 versus $41 893, P=0.04). The hazard ratio for death was 0.72 (confidence limits, 0.51 to 1.01) in the conservative strategy. The conservative strategy had lower costs and better outcomes in 76% of 1000 bootstrap replications, and a cost-effectiveness ratio below $50 000 per year of life added in 96% of replications. Conclusions-A conservative, ischemia-guided strategy of selective coronary angiography and revascularization for patients who develop objective evidence of recurrent ischemia is more cost-effective than a strategy of routine coronary angiography after uncomplicated non-Q-wave myocardial infarction.
引用
收藏
页码:680 / 684
页数:5
相关论文
共 21 条
  • [1] ONE-YEAR RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) IIIB CLINICAL-TRIAL - A RANDOMIZED COMPARISON OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR VERSUS PLACEBO AND EARLY INVASIVE VERSUS EARLY CONSERVATIVE STRATEGIES IN UNSTABLE ANGINA AND NON-Q-WAVE MYOCARDIAL-INFARCTION
    ANDERSON, HV
    CANNON, CP
    STONE, PH
    WILLIAMS, DO
    MCCABE, CH
    KNATTERUD, GL
    THOMPSON, B
    WILLERSON, JT
    BRAUNWALD, E
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (07) : 1643 - 1650
  • [2] ANDERSON RN, 2001, NATL VITAL STAT REPO, V48
  • [3] Highlights from the American College of Cardiology Forty-Ninth Annual Scientific Sessions: March 18 to 21, 2001
    Bahit, MC
    Cabell, CH
    Dyke, CK
    Felker, GM
    Kaul, P
    McGuire, DK
    Reddan, D
    East, M
    [J]. AMERICAN HEART JOURNAL, 2001, 142 (02) : 363 - 374
  • [4] Research without billing data - Econometric estimation of patient-specific costs
    Barnett, PG
    [J]. MEDICAL CARE, 1997, 35 (06) : 553 - 563
  • [5] Use of the Decision Support System for VA cost-effectiveness research
    Barnett, PG
    Rodgers, JH
    [J]. MEDICAL CARE, 1999, 37 (04) : AS63 - AS70
  • [6] Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy
    Boden, WE
    O'Rourke, RA
    Crawford, MH
    Blaustein, AS
    Deedwania, PC
    Zoble, RG
    Wexler, LF
    Kleiger, RE
    Pepine, CJ
    Ferry, DR
    Chow, BK
    Lavori, PW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (25) : 1785 - 1792
  • [7] Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Cannon, CP
    Weintraub, WS
    Demopoulos, LA
    Vicari, R
    Frey, MJ
    Lakkis, N
    Neumann, FJ
    Robertson, DH
    DeLucca, PT
    DiBattiste, PM
    Gibson, CM
    Braunwald, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) : 1879 - 1887
  • [9] Estimating the costs attributable to a disease with application to ovarian cancer
    Etzioni, R
    Urban, N
    Baker, M
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (01) : 95 - 103
  • [10] THE ASSOCIATION BETWEEN ON-SITE CARDIAC-CATHETERIZATION FACILITIES AND THE USE OF CORONARY ANGIOGRAPHY AFTER ACUTE MYOCARDIAL-INFARCTION
    EVERY, NR
    LARSON, EB
    LITWIN, PE
    MAYNARD, C
    FIHN, SD
    EISENBERG, MS
    HALLSTROM, AP
    MARTIN, JS
    WEAVER, WD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (08) : 546 - 551